Skip to main content
TipRanks
Go Ultimate75% OFF

David Y Liu Insider Profile

4 Followers

David Y Liu, Chief R&D Strategy Officer at Protagonist Therapeutics, holds 167.59K shares in Protagonist Therapeutics (Ticker: PTGX).

David Y Liu's Trading History

PTGX
Protagonist Therapeutics
Nov 17, 2022Chief R&D Strategy OfficerUninformative Buy231.80K$21.95M
PTGX
Insider Shares: 167.59K (0.34%)

David Y Liu has not reported any informative transactions for PTGX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 17, 2022Uninformative Buy$231.80K100,479$2.30―
Mar 02, 2022Uninformative Sell$51.45K2,119$24.28―
Feb 17, 2022Uninformative Buy$0.0010,000$0.00―
Aug 19, 2021Uninformative Sell$702.89K14,779$47.56―
Aug 19, 2021Uninformative Buy$8.70K10,000$0.87―

You May Also Like

David Y Liu insider profile FAQ

What stocks does David Y Liu hold?
David Y Liu holds: PTGX stocks.
What was David Y Liu’s latest transaction?
David Y Liu’s latest transaction was an Uninformative Buy of $231.80K.
What is David Y Liu's role in Protagonist Therapeutics?
David Y Liu's role in Protagonist Therapeutics is Chief R&D Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.